Literature DB >> 2556808

Chronic necrotising pulmonary aspergillosis treated with itraconazole.

J A Elliott1, L J Milne, D Cumming.   

Abstract

A patient with longstanding ankylosing spondylitis developed chronic necrotising pulmonary aspergillosis, which was successfully treated with itraconazole.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556808      PMCID: PMC1020850          DOI: 10.1136/thx.44.10.820

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Pleuropulmonary manifestations of ankylosing spondylitis.

Authors:  E Rosenow; C V Strimlan; J R Muhm; R H Ferguson
Journal:  Mayo Clin Proc       Date:  1977-10       Impact factor: 7.616

2.  The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).

Authors:  K De Beule; P De Doncker; G Cauwenbergh; M Koster; R Legendre; N Blatchford; J Daunas; E Chwetzoff
Journal:  Mycoses       Date:  1988-09       Impact factor: 4.377

3.  Morphological studies on clinical isolates of Aspergillus fumigatus.

Authors:  C E Leslie; B Flannigan; L J Milne
Journal:  J Med Vet Mycol       Date:  1988

4.  Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment.

Authors:  J Jewkes; P H Kay; M Paneth; K M Citron
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

5.  Intracavitary amphotereicin B in the treatment of symptomatic pulmonary aspergillomas.

Authors:  J L Hargis; R C Bone; J Stewart; N Rector; F C Hiller
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

Review 6.  Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity.

Authors:  R E Binder; L J Faling; R D Pugatch; C Mahasaen; G L Snider
Journal:  Medicine (Baltimore)       Date:  1982-03       Impact factor: 1.889

  6 in total
  4 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

2.  Proteus mirabilis as a cause of recurrent lung infection in a cystic fibrosis patient.

Authors:  M Ojeda-Vargas; A Pacheco; M Elia; R Villaverde; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

3.  Primary lymph node invasive aspergillosis.

Authors:  A Mazzoni; M Ferrarese; R Manfredi; A Facchini; C Sturani; A Nanetti
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

4.  Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy.

Authors:  Ariane Leboime; Jean-Marie Berthelot; Yannick Allanore; Lama Khalil-Kallouche; Philippe Herman; Philippe Orcel; Frédéric Lioté
Journal:  Arthritis Res Ther       Date:  2009-11-03       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.